Read the Beforeitsnews.com story here. Advertise at Before It's News here.
Profile image
By IPO Scoop (Reporter)
Contributor profile | More stories
Story Views
Now:
Last hour:
Last 24 hours:
Total:

The IPO Buzz: China’s WeRide (WRD Proposed) Rolls Out $109.7 Million IPO

% of readers think this story is Fact. Add your two cents.


China’s WeRide (WRD Proposed), which describes itself as the world’s only autonomous driving company with test permits in four countries, unveiled the terms of its $109.7 million IPO after the closing bell on Friday (Aug. 9, 2024). WeRide intends to price its IPO this week. WeRide rolled onto the IPO Calendar as the only sizable deal during the traditional slowdown in August, when a handful of small deals and a few SPACs have kept the IPO market’s wheels turning. Reuters highlighted this fact about the IPO’s timing: “The IPO announcement comes at a time when the Biden administration is expected to propose barring Chinese software in autonomous vehicles in the United States in the coming weeks.” WeRide plans to offer 6.45 million American Depositary Shares (6,452,000 ADS) at a price range of $15.50 to $18.50 to raise $109.7 million, if priced at the $17.00 mid-point of its range. Each ADS equals three ordinary shares. This is a  NASDAQ listing. The ADS offered in the IPO are being offered by WeRide, Inc., the Cayman Islands-incorporated holding company, and not by the underlying business based in Guangzhou, according to the prospectus. WeRide would have a market cap of about $5 billion, assuming that the IPO is priced at its $17.00 mid-point. Morgan Stanley, J.P. Morgan and CICC (China International Capital Corp.) are the lead joint book-runners of WeRide’s IPO. WeRide, founded in February 2017, cited a number of “firsts” and milestones in the prospectus: *First autonomous driving company in the world with products operating and testing in 30 cities across seven countries; *The only autonomous driving company in the world to obtain test permits for autonomous driving vehicles in four countries – mainland China, its home; the U.S.; the United Arab Emirates (UAE) and Singapore. *First company in the world to offer paid L4 robotaxi services to the public – with L4 (and higher levels) defined in the prospectus as when “vehicles become truly driverless, allowing (a) human to be completely free of the task of driving and the vehicles are capable of performing all driving functions under common weather conditions.” *First company in the world to develop a purpose-built L4 robobus designed for the open road, as well as the first to launch driverless robobus services on the open road to the public; *First autonomous driving company in the world to accumulate 10,000 purpose-built L4 autonomous driving vehicle orders, and *The only autonomous driving company to achieve mass production of an ADAS solution within 18 months into development, the quickest among peers. (ADAS is an acronym that stands for advanced driver-assistance system.) All of those “firsts” and milestones, however, have not built up WeRide’s bottom line so far. WeRide reported a net loss that was nearly five times its revenue in 2023: Net loss of $268.2 million on revenue of $55.3 million for the 12 months that ended Dec. 31, 2023, according to the prospectus. Light August Traffic The rest of this week’s IPO Calendar shows light traffic, typical for August. Six small IPOs are on this week’s roster as possibly pricing this week. Five of those six deals are NASDAQ listings. The lineup includes: Trident Digital Tech Holdings Ltd. (TDTH Proposed), a carry-over from last week. Trident Digital Tech Holdings Ltd. is the parent of  a Singapore company that serves small to medium-sized enterprises (SMEs) by providing digital transformation services, including e-commerce sites and data analysis. Trident Digital Tech Holdings Ltd. plans to raise $10.8 million by offering 1.8 million American Depositary Shares (ADS) at a price range of $5.00 to $7.00. The pricing date is indicated as sometime during the week of Aug. 12, 2024. WallachBeth Capital and Revere Securities are the joint book-runners, according to the prospectus. This is a NASDAQ listing. Stay tuned. (For more information about these companies, please check the IPO Calendar and the individual IPO Profiles found on IPOScoop.com’s website.) Note: Never trade on proposed symbols. They have been known to change and you might buy something on the OTC Bulletin Board. To see what time the NASDAQ IPOs are expected to trade, please log in to: NASDAQTrader.com then scroll down to IPO Message. Disclosure: Nobody on the IPOScoop.com staff has a position in any stocks mentioned above, nor do they trade or invest in IPOs. The IPOScoop.com staff does not issue advice, recommendations or opinions. Disclaimer: A SCOOP Rating (Wall Street Consensus of Opening-day Premiums) is a general consensus taken, at press time, from Wall Street and investment professionals concerning how well an IPO might perform when it starts trading. The SCOOP Rating does not reflect the opinions of anyone associated with IPOScoop.com. The SCOOP ratings should not be taken as investment advice. The rating merely reflects the opinion of the professionals at the time of publication and is subject to last-minute changes due to market conditions, changes in a specific offering and other factors, such as changes in the proposed offering terms and the shifting of investor interest in the IPO. The information offered is taken from sources we believe to be reliable, but we cannot guarantee the accuracy.  


Source: https://www.iposcoop.com/the-ipo-buzz-chinas-weride-wrd-proposed-rolls-out-109-7-million-ipo/



Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world.

Anyone can join.
Anyone can contribute.
Anyone can become informed about their world.

"United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.

Lion’s Mane Mushroom Nootropic

Mushrooms are having a moment. One fabulous fungus in particular, lion’s mane, may help improve memory, depression and anxiety symptoms. They are also an excellent source of nutrients that show promise as a therapy for dementia, and other neurodegenerative diseases. If you’re living with anxiety or depression, you may be curious about all the therapy options out there — including the natural ones.Our Lion’s Mane WHOLE MIND Nootropic Blend has been formulated to utilize the potency of Lion’s mane but also include the benefits of four other Highly Beneficial Mushrooms. Synergistically, they work together to Build your health through improving cognitive function and immunity regardless of your age. Our Nootropic not only improves your Cognitive Function and Activates your Immune System, But it benefits growth of Essential Gut Flora, further enhancing your Vitality.


 


Our Formula includes: Lion’s Mane Mushrooms which Increase Brain Power through nerve growth, lessen anxiety, reduce depression, and improve concentration. Its an excellent adaptogen, promotes sleep and improves immunity.


Shiitake Mushrooms which Fight cancer cells and infectious disease, boost the immune system, promotes brain function, and serves as a source of B vitamins.


Maitake Mushrooms which regulate blood sugar levels of diabetics, reduce hypertension and boosts the immune system.


Reishi Mushrooms which Fight inflammation, liver disease, fatigue, tumor growth and cancer. They Improve skin disorders and soothes digestive problems, stomach ulcers and leaky gut syndrome.


Chaga Mushrooms which have anti-aging effects, boost immune function, improve stamina and athletic performance, even act as a natural aphrodisiac, fighting diabetes and improving liver function.


Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules Today. Be 100% Satisfied or Receive a Full Money Back Guarantee. Order Yours Today by Following This Link.

Report abuse

Comments

Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

MOST RECENT
Load more ...

SignUp

Login

Newsletter

Email this story
Email this story

If you really want to ban this commenter, please write down the reason:

If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.